PDB Short entry for 2AOT HEADER TRANSFERASE 14-AUG-05 2AOT TITLE HISTAMINE METHYLTRANSFERASE COMPLEXED WITH THE ANTIHISTAMINE DRUG TITLE 2 DIPHENHYDRAMINE COMPND MOL_ID: 1; COMPND 2 MOLECULE: HISTAMINE N-METHYLTRANSFERASE; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: HMT; COMPND 5 EC: 2.1.1.8; COMPND 6 ENGINEERED: YES; COMPND 7 MOL_ID: 2; COMPND 8 MOLECULE: HISTAMINE N-METHYLTRANSFERASE; COMPND 9 CHAIN: B; COMPND 10 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: HNMT; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: DH5A; SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PGEX-4T-3; SOURCE 11 MOL_ID: 2; SOURCE 12 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 13 ORGANISM_COMMON: HUMAN; SOURCE 14 ORGANISM_TAXID: 9606; SOURCE 15 GENE: HNMT; SOURCE 16 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 17 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 18 EXPRESSION_SYSTEM_STRAIN: DH5A; SOURCE 19 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 20 EXPRESSION_SYSTEM_PLASMID: PGEX-4T-3 KEYWDS CLASSIC METHYLTRANSFERASE FOLD, PROTEIN-DRUG COMPLEX, TRANSFERASE EXPDTA X-RAY DIFFRACTION AUTHOR J.R.HORTON,K.SAWADA,M.NISHIBORI,X.CHENG REVDAT 5 15-NOV-23 2AOT 1 REMARK REVDAT 4 23-AUG-23 2AOT 1 REMARK SEQADV HETSYN LINK REVDAT 3 24-FEB-09 2AOT 1 VERSN REVDAT 2 18-OCT-05 2AOT 1 JRNL REVDAT 1 13-SEP-05 2AOT 0 JRNL AUTH J.R.HORTON,K.SAWADA,M.NISHIBORI,X.CHENG JRNL TITL STRUCTURAL BASIS FOR INHIBITION OF HISTAMINE JRNL TITL 2 N-METHYLTRANSFERASE BY DIVERSE DRUGS JRNL REF J.MOL.BIOL. V. 353 334 2005 JRNL REFN ISSN 0022-2836 JRNL PMID 16168438 JRNL DOI 10.1016/J.JMB.2005.08.040 REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH J.R.HORTON,K.SAWADA,M.NISHIBORI,X.ZHANG,X.CHENG REMARK 1 TITL POLYMORPHIC FORMS OF HUMAN HISTAMINE METHYLTRANSFERASE: REMARK 1 TITL 2 STRUCTURAL, THERMAL, AND KINETIC COMPARISONS REMARK 1 REF STRUCTURE V. 9 837 2001 REMARK 1 REFN ISSN 0969-2126 REMARK 2 REMARK 2 RESOLUTION. 1.90 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : ENGH & HUBER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.90 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 35.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : NULL REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 NUMBER OF REFLECTIONS : 47506 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.221 REMARK 3 FREE R VALUE : 0.256 REMARK 3 FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 FREE R VALUE TEST SET COUNT : 4792 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : NULL REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.90 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 1.94 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 REFLECTIONS IN BIN (WORKING SET) : NULL REMARK 3 BIN R VALUE (WORKING SET) : 0.2550 REMARK 3 BIN FREE R VALUE : 0.2820 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 BIN FREE R VALUE TEST SET COUNT : 291 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.017 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 4404 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 90 REMARK 3 SOLVENT ATOMS : 337 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 16.50 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 32.40 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 0.57000 REMARK 3 B22 (A**2) : 0.57000 REMARK 3 B33 (A**2) : 1.13000 REMARK 3 B12 (A**2) : 1.23000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.24 REMARK 3 ESD FROM SIGMAA (A) : 0.14 REMARK 3 LOW RESOLUTION CUTOFF (A) : 35.0 REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : 0.28 REMARK 3 ESD FROM C-V SIGMAA (A) : 0.16 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.031 REMARK 3 BOND ANGLES (DEGREES) : 1.400 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 22.70 REMARK 3 IMPROPER ANGLES (DEGREES) : 1.100 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : ANISOTROPHIC REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : NULL REMARK 3 KSOL : NULL REMARK 3 BSOL : NULL REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : NULL REMARK 3 TOPOLOGY FILE 1 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 2AOT COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 25-AUG-05. REMARK 100 THE DEPOSITION ID IS D_1000034142. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 11-NOV-00 REMARK 200 TEMPERATURE (KELVIN) : 173 REMARK 200 PH : 6.0 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : NSLS REMARK 200 BEAMLINE : X26C REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.1 REMARK 200 MONOCHROMATOR : SI(111) DOUBLE-CRYSTAL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 4 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 47507 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.900 REMARK 200 RESOLUTION RANGE LOW (A) : 35.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 95.5 REMARK 200 DATA REDUNDANCY : 4.500 REMARK 200 R MERGE (I) : 0.06800 REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 24.8000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.90 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.94 REMARK 200 COMPLETENESS FOR SHELL (%) : 95.2 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : 0.25000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: GLRF REMARK 200 STARTING MODEL: PDB ENTRY 1JQD REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 51.00 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.51 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PEG 6000, MES, ETHYLENEGLYCOL, PH 6.0, REMARK 280 VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 289K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 6 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -Y,X-Y,Z REMARK 290 3555 -X+Y,-X,Z REMARK 290 4555 -X,-Y,Z REMARK 290 5555 Y,-X+Y,Z REMARK 290 6555 X-Y,X,Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 2 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 3 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 3 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 5 0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 5 -0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 5 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 6 0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 6 0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 6 0.000000 0.000000 1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 1 REMARK 465 ALA A 2 REMARK 465 SER A 3 REMARK 465 SER A 4 REMARK 465 MET B 1 REMARK 465 ALA B 2 REMARK 465 SER B 3 REMARK 465 SER B 4 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 ARG A 6 CG CD NE CZ NH1 NH2 REMARK 470 ASP A 11 CG OD1 OD2 REMARK 470 TYR A 15 CG CD1 CD2 CE1 CE2 CZ OH REMARK 470 ARG A 20 CG CD NE CZ NH1 NH2 REMARK 470 ARG A 21 CG CD NE CZ NH1 NH2 REMARK 470 ASN A 24 CB CG OD1 ND2 REMARK 470 HIS A 25 CG ND1 CD2 CE1 NE2 REMARK 470 GLU A 93 CG CD OE1 OE2 REMARK 470 GLU A 100 CG CD OE1 OE2 REMARK 470 LYS A 104 CG CD CE NZ REMARK 470 GLU A 109 CG CD OE1 OE2 REMARK 470 LYS A 130 CG CD CE NZ REMARK 470 LYS A 131 CG CD CE NZ REMARK 470 GLU A 132 CG CD OE1 OE2 REMARK 470 GLN A 134 CG CD OE1 NE2 REMARK 470 GLN A 192 CG CD OE1 NE2 REMARK 470 ASP A 193 CG OD1 OD2 REMARK 470 LYS A 214 CG CD CE NZ REMARK 470 ASP A 225 CB CG OD1 OD2 REMARK 470 ASP A 228 CG OD1 OD2 REMARK 470 PHE A 230 CG CD1 CD2 CE1 CE2 CZ REMARK 470 ILE A 231 CG1 CG2 CD1 REMARK 470 ASP A 232 CG OD1 OD2 REMARK 470 LEU A 239 CG CD1 CD2 REMARK 470 GLU A 246 CG CD OE1 OE2 REMARK 470 ASN A 251 CG OD1 ND2 REMARK 470 THR A 253 OG1 CG2 REMARK 470 LYS A 264 CG CD CE NZ REMARK 470 GLN A 267 CG CD OE1 NE2 REMARK 470 GLU A 270 CG CD OE1 OE2 REMARK 470 LYS A 274 CG CD CE NZ REMARK 470 LYS A 275 CG CD CE NZ REMARK 470 GLU A 276 CG CD OE1 OE2 REMARK 470 LYS A 278 CG CD CE NZ REMARK 470 VAL A 279 CG1 CG2 REMARK 470 SER B 10 OG REMARK 470 ASP B 11 CG OD1 OD2 REMARK 470 LYS B 14 CG CD CE NZ REMARK 470 GLU B 17 CG CD OE1 OE2 REMARK 470 ARG B 20 CG CD NE CZ NH1 NH2 REMARK 470 GLU B 65 CG CD OE1 OE2 REMARK 470 GLU B 109 CG CD OE1 OE2 REMARK 470 LYS B 112 CG CD CE NZ REMARK 470 LYS B 131 CG CD CE NZ REMARK 470 GLU B 132 CG CD OE1 OE2 REMARK 470 GLN B 192 CG CD OE1 NE2 REMARK 470 ASP B 193 CG OD1 OD2 REMARK 470 ASP B 194 CG OD1 OD2 REMARK 470 LEU B 195 CG CD1 CD2 REMARK 470 ASP B 228 CG OD1 OD2 REMARK 470 ASP B 232 CG OD1 OD2 REMARK 470 ASN B 234 CG OD1 ND2 REMARK 470 ASP B 257 CG OD1 OD2 REMARK 470 GLU B 270 CG CD OE1 OE2 REMARK 470 LYS B 274 CG CD CE NZ REMARK 470 LYS B 275 CG CD CE NZ REMARK 470 GLU B 276 CG CD OE1 OE2 REMARK 470 LYS B 278 CG CD CE NZ REMARK 470 VAL B 279 CG1 CG2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 SER A 10 37.73 -88.20 REMARK 500 ASP A 11 81.05 -167.97 REMARK 500 ASP A 225 98.63 -57.79 REMARK 500 ASN A 249 71.13 52.58 REMARK 500 ASN A 251 22.22 -64.78 REMARK 500 ALA A 252 -7.57 -156.23 REMARK 500 ASN B 24 3.68 -67.17 REMARK 500 GLU B 28 -73.81 -44.91 REMARK 500 THR B 50 -0.21 74.13 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 2PM A 400 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 2PM B 401 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SAH A 500 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SAH B 501 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1JQD RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE ANALYSIS OF HUMAN HISTAMINE METHYLTRANSFERASE REMARK 900 (THR105 POLYMORPHIC VARIANT) COMPLEXED WITH ADOHCY AND HISTAMINE REMARK 900 RELATED ID: 1JQE RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE ANALYSIS OF HUMAN HISTAMINE METHYLTRANSFERASE REMARK 900 (ILE105 POLYMORPHIC VARIANT) COMPLEXED WITH ADOHCY AND ANTIMALARIAL REMARK 900 DRUG QUINACRINE REMARK 900 RELATED ID: 2AOU RELATED DB: PDB REMARK 900 RELATED ID: 2AOV RELATED DB: PDB REMARK 900 RELATED ID: 2AOW RELATED DB: PDB REMARK 900 RELATED ID: 2AOX RELATED DB: PDB DBREF 2AOT A 1 292 UNP P50135 HNMT_HUMAN 1 292 DBREF 2AOT B 1 292 UNP P50135 HNMT_HUMAN 1 292 SEQADV 2AOT CYS A 82 UNP P50135 CYS 82 MODIFIED RESIDUE SEQADV 2AOT CSO A 217 UNP P50135 CYS 217 MODIFIED RESIDUE SEQADV 2AOT CSO A 248 UNP P50135 CYS 248 MODIFIED RESIDUE SEQADV 2AOT CSO B 82 UNP P50135 CYS 82 MODIFIED RESIDUE SEQADV 2AOT CYS B 217 UNP P50135 CYS 217 MODIFIED RESIDUE SEQADV 2AOT CSO B 248 UNP P50135 CYS 248 MODIFIED RESIDUE SEQRES 1 A 292 MET ALA SER SER MET ARG SER LEU PHE SER ASP HIS GLY SEQRES 2 A 292 LYS TYR VAL GLU SER PHE ARG ARG PHE LEU ASN HIS SER SEQRES 3 A 292 THR GLU HIS GLN CYS MET GLN GLU PHE MET ASP LYS LYS SEQRES 4 A 292 LEU PRO GLY ILE ILE GLY ARG ILE GLY ASP THR LYS SER SEQRES 5 A 292 GLU ILE LYS ILE LEU SER ILE GLY GLY GLY ALA GLY GLU SEQRES 6 A 292 ILE ASP LEU GLN ILE LEU SER LYS VAL GLN ALA GLN TYR SEQRES 7 A 292 PRO GLY VAL CYS ILE ASN ASN GLU VAL VAL GLU PRO SER SEQRES 8 A 292 ALA GLU GLN ILE ALA LYS TYR LYS GLU LEU VAL ALA LYS SEQRES 9 A 292 THR SER ASN LEU GLU ASN VAL LYS PHE ALA TRP HIS LYS SEQRES 10 A 292 GLU THR SER SER GLU TYR GLN SER ARG MET LEU GLU LYS SEQRES 11 A 292 LYS GLU LEU GLN LYS TRP ASP PHE ILE HIS MET ILE GLN SEQRES 12 A 292 MET LEU TYR TYR VAL LYS ASP ILE PRO ALA THR LEU LYS SEQRES 13 A 292 PHE PHE HIS SER LEU LEU GLY THR ASN ALA LYS MET LEU SEQRES 14 A 292 ILE ILE VAL VAL SER GLY SER SER GLY TRP ASP LYS LEU SEQRES 15 A 292 TRP LYS LYS TYR GLY SER ARG PHE PRO GLN ASP ASP LEU SEQRES 16 A 292 CYS GLN TYR ILE THR SER ASP ASP LEU THR GLN MET LEU SEQRES 17 A 292 ASP ASN LEU GLY LEU LYS TYR GLU CSO TYR ASP LEU LEU SEQRES 18 A 292 SER THR MET ASP ILE SER ASP CYS PHE ILE ASP GLY ASN SEQRES 19 A 292 GLU ASN GLY ASP LEU LEU TRP ASP PHE LEU THR GLU THR SEQRES 20 A 292 CSO ASN PHE ASN ALA THR ALA PRO PRO ASP LEU ARG ALA SEQRES 21 A 292 GLU LEU GLY LYS ASP LEU GLN GLU PRO GLU PHE SER ALA SEQRES 22 A 292 LYS LYS GLU GLY LYS VAL LEU PHE ASN ASN THR LEU SER SEQRES 23 A 292 PHE ILE VAL ILE GLU ALA SEQRES 1 B 292 MET ALA SER SER MET ARG SER LEU PHE SER ASP HIS GLY SEQRES 2 B 292 LYS TYR VAL GLU SER PHE ARG ARG PHE LEU ASN HIS SER SEQRES 3 B 292 THR GLU HIS GLN CYS MET GLN GLU PHE MET ASP LYS LYS SEQRES 4 B 292 LEU PRO GLY ILE ILE GLY ARG ILE GLY ASP THR LYS SER SEQRES 5 B 292 GLU ILE LYS ILE LEU SER ILE GLY GLY GLY ALA GLY GLU SEQRES 6 B 292 ILE ASP LEU GLN ILE LEU SER LYS VAL GLN ALA GLN TYR SEQRES 7 B 292 PRO GLY VAL CSO ILE ASN ASN GLU VAL VAL GLU PRO SER SEQRES 8 B 292 ALA GLU GLN ILE ALA LYS TYR LYS GLU LEU VAL ALA LYS SEQRES 9 B 292 THR SER ASN LEU GLU ASN VAL LYS PHE ALA TRP HIS LYS SEQRES 10 B 292 GLU THR SER SER GLU TYR GLN SER ARG MET LEU GLU LYS SEQRES 11 B 292 LYS GLU LEU GLN LYS TRP ASP PHE ILE HIS MET ILE GLN SEQRES 12 B 292 MET LEU TYR TYR VAL LYS ASP ILE PRO ALA THR LEU LYS SEQRES 13 B 292 PHE PHE HIS SER LEU LEU GLY THR ASN ALA LYS MET LEU SEQRES 14 B 292 ILE ILE VAL VAL SER GLY SER SER GLY TRP ASP LYS LEU SEQRES 15 B 292 TRP LYS LYS TYR GLY SER ARG PHE PRO GLN ASP ASP LEU SEQRES 16 B 292 CYS GLN TYR ILE THR SER ASP ASP LEU THR GLN MET LEU SEQRES 17 B 292 ASP ASN LEU GLY LEU LYS TYR GLU CYS TYR ASP LEU LEU SEQRES 18 B 292 SER THR MET ASP ILE SER ASP CYS PHE ILE ASP GLY ASN SEQRES 19 B 292 GLU ASN GLY ASP LEU LEU TRP ASP PHE LEU THR GLU THR SEQRES 20 B 292 CSO ASN PHE ASN ALA THR ALA PRO PRO ASP LEU ARG ALA SEQRES 21 B 292 GLU LEU GLY LYS ASP LEU GLN GLU PRO GLU PHE SER ALA SEQRES 22 B 292 LYS LYS GLU GLY LYS VAL LEU PHE ASN ASN THR LEU SER SEQRES 23 B 292 PHE ILE VAL ILE GLU ALA MODRES 2AOT CSO A 217 CYS S-HYDROXYCYSTEINE MODRES 2AOT CSO A 248 CYS S-HYDROXYCYSTEINE MODRES 2AOT CSO B 82 CYS S-HYDROXYCYSTEINE MODRES 2AOT CSO B 248 CYS S-HYDROXYCYSTEINE HET CSO A 217 7 HET CSO A 248 7 HET CSO B 82 13 HET CSO B 248 7 HET 2PM A 400 19 HET SAH A 500 26 HET 2PM B 401 19 HET SAH B 501 26 HETNAM CSO S-HYDROXYCYSTEINE HETNAM 2PM N-[2-(BENZHYDRYLOXY)ETHYL]-N,N-DIMETHYLAMINE HETNAM SAH S-ADENOSYL-L-HOMOCYSTEINE HETSYN 2PM DIPHENHYDRAMINE; ANTISTOMINUM; BENZHYDRAMINE FORMUL 1 CSO 4(C3 H7 N O3 S) FORMUL 3 2PM 2(C17 H21 N O) FORMUL 4 SAH 2(C14 H20 N6 O5 S) FORMUL 7 HOH *337(H2 O) HELIX 1 1 SER A 7 SER A 10 5 4 HELIX 2 2 ASP A 11 ASN A 24 1 14 HELIX 3 3 THR A 27 LYS A 39 1 13 HELIX 4 4 LYS A 39 ILE A 44 1 6 HELIX 5 5 GLY A 64 TYR A 78 1 15 HELIX 6 6 SER A 91 LYS A 104 1 14 HELIX 7 7 THR A 119 GLU A 129 1 11 HELIX 8 8 MET A 144 VAL A 148 5 5 HELIX 9 9 ASP A 150 LEU A 161 1 12 HELIX 10 10 SER A 177 GLY A 187 1 11 HELIX 11 11 SER A 188 PHE A 190 5 3 HELIX 12 12 THR A 200 GLY A 212 1 13 HELIX 13 13 SER A 227 ILE A 231 5 5 HELIX 14 14 ASN A 234 GLU A 246 1 13 HELIX 15 15 ASN A 249 ALA A 254 1 6 HELIX 16 16 PRO A 255 LEU A 266 1 12 HELIX 17 17 SER B 7 SER B 10 5 4 HELIX 18 18 ASP B 11 ASN B 24 1 14 HELIX 19 19 THR B 27 LYS B 39 1 13 HELIX 20 20 LYS B 39 GLY B 45 1 7 HELIX 21 21 GLY B 64 TYR B 78 1 15 HELIX 22 22 SER B 91 LYS B 104 1 14 HELIX 23 23 THR B 119 LEU B 128 1 10 HELIX 24 24 MET B 144 VAL B 148 5 5 HELIX 25 25 ASP B 150 LEU B 161 1 12 HELIX 26 26 SER B 177 GLY B 187 1 11 HELIX 27 27 SER B 188 PHE B 190 5 3 HELIX 28 28 THR B 200 GLY B 212 1 13 HELIX 29 29 SER B 227 ILE B 231 5 5 HELIX 30 30 ASN B 234 GLU B 246 1 13 HELIX 31 31 ASN B 249 ALA B 254 1 6 HELIX 32 32 PRO B 255 GLN B 267 1 13 SHEET 1 A 7 VAL A 111 HIS A 116 0 SHEET 2 A 7 CYS A 82 VAL A 88 1 N ILE A 83 O LYS A 112 SHEET 3 A 7 GLU A 53 ILE A 59 1 N SER A 58 O VAL A 88 SHEET 4 A 7 TRP A 136 ILE A 142 1 O HIS A 140 N ILE A 59 SHEET 5 A 7 LEU A 162 VAL A 173 1 O GLY A 163 N TRP A 136 SHEET 6 A 7 LEU A 285 GLU A 291 -1 O ILE A 290 N MET A 168 SHEET 7 A 7 TYR A 215 LEU A 220 -1 N TYR A 218 O PHE A 287 SHEET 1 B 3 THR A 223 ASP A 225 0 SHEET 2 B 3 LYS A 278 ASN A 282 -1 O PHE A 281 N MET A 224 SHEET 3 B 3 SER A 272 LYS A 275 -1 N ALA A 273 O LEU A 280 SHEET 1 C 7 VAL B 111 HIS B 116 0 SHEET 2 C 7 CSO B 82 VAL B 88 1 N VAL B 87 O HIS B 116 SHEET 3 C 7 GLU B 53 ILE B 59 1 N ILE B 56 O ASN B 84 SHEET 4 C 7 TRP B 136 ILE B 142 1 O HIS B 140 N ILE B 59 SHEET 5 C 7 LEU B 162 VAL B 173 1 O GLY B 163 N TRP B 136 SHEET 6 C 7 LEU B 285 GLU B 291 -1 O ILE B 290 N MET B 168 SHEET 7 C 7 TYR B 215 LEU B 220 -1 N TYR B 218 O PHE B 287 SHEET 1 D 3 THR B 223 ASP B 225 0 SHEET 2 D 3 LYS B 278 ASN B 282 -1 O PHE B 281 N MET B 224 SHEET 3 D 3 SER B 272 LYS B 275 -1 N ALA B 273 O LEU B 280 LINK C GLU A 216 N CSO A 217 1555 1555 1.33 LINK C CSO A 217 N TYR A 218 1555 1555 1.33 LINK C THR A 247 N CSO A 248 1555 1555 1.33 LINK C CSO A 248 N ASN A 249 1555 1555 1.33 LINK C VAL B 81 N ACSO B 82 1555 1555 1.33 LINK C VAL B 81 N BCSO B 82 1555 1555 1.33 LINK C BCSO B 82 N ILE B 83 1555 1555 1.32 LINK C ACSO B 82 N ILE B 83 1555 1555 1.32 LINK C THR B 247 N CSO B 248 1555 1555 1.33 LINK C CSO B 248 N ASN B 249 1555 1555 1.33 SITE 1 AC1 8 TYR A 146 TYR A 147 TRP A 179 TRP A 183 SITE 2 AC1 8 GLN A 197 TYR A 198 PHE A 243 HOH A 653 SITE 1 AC2 12 TYR B 15 PHE B 22 TYR B 146 TYR B 147 SITE 2 AC2 12 TRP B 179 TRP B 183 CYS B 196 GLN B 197 SITE 3 AC2 12 TYR B 198 PHE B 243 GLU B 246 HOH B 685 SITE 1 AC3 16 GLY A 60 GLY A 62 ILE A 66 GLU A 89 SITE 2 AC3 16 PRO A 90 GLN A 94 THR A 119 SER A 120 SITE 3 AC3 16 ILE A 142 GLN A 143 MET A 144 TYR A 147 SITE 4 AC3 16 HOH A 512 HOH A 513 HOH A 529 HOH A 559 SITE 1 AC4 20 HIS B 29 GLY B 60 GLY B 61 GLY B 62 SITE 2 AC4 20 GLU B 89 PRO B 90 GLN B 94 THR B 119 SITE 3 AC4 20 SER B 120 ILE B 142 GLN B 143 MET B 144 SITE 4 AC4 20 TYR B 147 HOH B 511 HOH B 515 HOH B 526 SITE 5 AC4 20 HOH B 533 HOH B 560 HOH B 567 HOH B 607 CRYST1 131.670 131.670 63.750 90.00 90.00 120.00 P 6 6 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.007595 0.004385 0.000000 0.00000 SCALE2 0.000000 0.008770 0.000000 0.00000 SCALE3 0.000000 0.000000 0.015687 0.00000